Squire Investment Management Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Buy
1,057
+23
+2% +$4.95K 0.06% 77
2026
Q1
$225K Sell
1,034
-2
-0.2% -$444 0.06% 72
2025
Q4
$237K Buy
1,036
+32
+3% +$7.29K 0.07% 67
2025
Q3
$232K Buy
+1,004
New +$204K 0.08% 65

Other funds holding ABBV

Squire Investment Management Company's ABBV Position: Q2 2026 in Review

Squire Investment Management Company increased its AbbVie (ABBV) stake by 2.2% in Q2 2026, buying an estimated $4.95K and bringing the position to 1,057 shares worth $266K. The position accounts for 0.06% of the portfolio, ranked #77.

Squire Investment Management Company first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Squire Investment Management Company held 1,057 shares of AbbVie worth $266K as of Q2 2026.
  • Squire Investment Management Company bought 23 AbbVie shares in Q2 2026, an estimated $4.95K.
  • AbbVie made up 0.06% of Squire Investment Management Company's portfolio in Q2 2026, its #77 holding.
  • Squire Investment Management Company first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Squire Investment Management Company's 13F filing for Q2 2026, filed 28 Jul 2026.